作者：
Mackie,S.L. [1]
;
Arat,S. [2]
;
DaSilva,J. [3]
;
Duarte,C. [4]
;
Halliday,S. [5]
;
Hughes,R. [6]
;
Morris,M. [7]
;
Pease,C.T. [8]
;
Sherman,J.W. [9]
;
Simon,L.S. [10]
;
Walsh,M. [11]
;
Westhovens,R. ;
Zakout,S. ;
Kirwan,J.R.
作者单位：
Department of Rheumatology, Katholieke Universiteit Leuven, Leuven, Belgium
[1]
Leeds Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine
[2]
Department of Rheumatology, Ashford St Peter's Hospitals National Health Service (NHS) Foundation
[3]
Department of Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
[4]
Centre for Health and Clinical Research, Faculty of Health and Life Sciences, University of the
[5]
Rheumatology Department, Centro Hospitalar, Universitário de Coimbra, Coimbra, Portugal
[6]
Academic Rheumatology Unit, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW
[7]
Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium
[8]
SDG LLC, Boston, MA, United States
[9]
Polymyalgia Rheumatica Giant Cell Arteritis (PMRGCA), Bristol, United Kingdom
[10]
Horizon Pharma Inc., Deerfield, IL, United States
[11]
发布时间
2014-06-29
换一批
换一批
